Teaser A new engineered human immunoglobulin (Ig)G anti-yellow fever virus monoclonal antibody suggested potential clinical benefit in Phase 1a and 1b clinical trial. Click to show full abstract
Teaser A new engineered human immunoglobulin (Ig)G anti-yellow fever virus monoclonal antibody suggested potential clinical benefit in Phase 1a and 1b clinical trial.
               
Click one of the above tabs to view related content.